Abstract:The interaction of exogenous carnitine with whole body carnitine homeostasis was characterized in the rat. Carnitine was administered in pharmacologic doses (0-33.3 mumols/100 g body weight) by bolus, intravenous injection, and plasma, urine, liver, skeletal muscle and heart content of carnitine and acylcarnitines quantitated over a 48 h period. Pre-injection urinary carnitine excretion was circadian as excretion rates were increased 2-fold during the lights-off cycle as compared with the lights-on cycle. Following carnitine administration, there was an increase in urinary total carnitine excretion which accounted for approx. 60% of the administered carnitine at doses above 8.3 mumols/100 g body weight. Urinary acylcarnitine excretion was increased following carnitine administration in a dose-dependent fashion. During the 24 h following administration of 16.7 mumols [14C]carnitine/100 g body weight, urinary carnitine specific activity averaged only 72 +/- 4% of the injection solution specific activity. This dilution of the [14C]carnitine specific activity suggests that endogenous carnitine contributed to the increased net urinary carnitine excretion following carnitine administration. 5 min after administration of 16.7 mumol carnitine/100 g body weight approx. 80% of the injected carnitine was in the extracellular fluid compartment and 5% in the liver. Plasma, liver and soleus total carnitine contents were increased 6 h after administration of 16.7 mumols carnitine/100 g body weight. 6 h post-administration, 37% of the dose was recovered in the urine, 12% remained in the extracellular compartment, 9% was in the liver and 22% was distributed in the skeletal muscle. In liver and plasma, short chain acylcarnitine content was increased 5 min and 6 h post injection as compared with controls. Plasma, liver, skeletal muscle and heart carnitine contents were not different from control levels 48 h after carnitine administration. The results demonstrate that single, bolus administration of carnitine is effective in increasing urinary acylcarnitine elimination. While liver carnitine content is doubled for at least 6 h following carnitine administration, skeletal muscle and heart carnitine pools are only modestly perturbed following a single intravenous carnitine dose. The dilution of [14C]carnitine specific activity in the urine of treated animals suggests that tissue-blood carnitine or acylcarnitine exchange systems contribute to overall carnitine homeostasis following carnitine administration.

EFFECT OF MEDIUM CHAIN TRIGLYCERIDE (MCT) ADMINISTRATION ON CARNITINE METABOLISM IN THE ANESTHESIZED PIGLET AND CULTURED KIDNEY EPITHELIAL CELLS

Effect of exogenous carnitine on carnitine homeostasis in the rat

Repeated administration of pharmaceutical-grade medium chain triglycerides, a common pharmacologic excipient, confers dose-dependent toxicity by the intraperitoneal but not oral route in mice*

Growth Performance, Plasma Fatty Acids, Villous Height and Crypt Depth of Preweaning Piglets Fed with Medium Chain Triacylglycerol

Effects of Augmented Delivery of Pyruvate on Myocardial High-Energy Phosphate Metabolism at High Workstate

Ketogenic Response to Medium-Chain Triglyceride Load in the Rat

The Effect of L-Carnitine Use on Some Blood Parameters, Milk Yield, Milk Composition, and Live Weight in the Transition Period of Dairy Cows

Response to Weaning and Dietary L-G Lutamine Supp Lementation: Metabo Lomic Ana Lysis in Pig Lets by Gas Chromatography/mass Spectrometry

Chronic oral ingestion of l‐carnitine and carbohydrate increases muscle carnitine content and alters muscle fuel metabolism during exercise in humans

Nutritional and physiological role of medium-chain triglycerides and medium-chain fatty acids in piglets

Cellular Uptake of MCT1 Inhibitors AR-C155858 and AZD3965 and Their Effects on MCT-Mediated Transport of L-Lactate in Murine 4T1 Breast Tumor Cancer Cells

Metabolic Effects of Medium-Chain Triacylglycerol Consumption are Preserved in Obesity

Roles of long chain fatty acids and carnitine in mitochondrial membrane permeability transition

Multiple AMPK activators inhibit l-carnitine uptake in C2C12 skeletal muscle myotubes

EFFECTS OF L-CARNITINE THERAPY ON FAT AND GLUCOSE METABOLISM AMONG MELDONIUM INDUCED CARNITINE DEPLETION IN ALBINO WISTAR RATS

The effect of short chain fatty acid administration on hepatic glucose, phosphate, magnesium and calcium metabolism

Regulation of lipid flux between liver and adipose tissue during transient hepatic steatosis in carnitine-depleted rats

Effect of L-Carnitine and Source of Dietary Fat on Growth Performance and Serum Biochemical Parameters of Piglets Weaned at 35 Days of Age

Effect of Enteral Supplement of Medium Chain Triglyceride on Fat Metabolism and Intestinal Adaptation in Rats with Short Bowel Syndrome

Medium-Chain Fatty Acid Feeding Reduces Oxidation and Causes Panacinar Steatosis in Livers of Neonatal Pigs

Effects of a Dietary L-Carnitine Supplementation on Performance, Energy Metabolism and Recovery from Calving in Dairy Cows